POWELL, OH - January 08, 2026 - PRESSADVANTAGE - Be Aligned Health, a chiropractic office based in Powell, Ohio, ...

A massive 243-kilogram (535-pound) bluefin tuna sold for a record 510 million yen ($3.2 million) at the first auction of 2026 ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...

Abstract: This article aims to demonstrate the 3-D harmonic function characteristics and modulation theory of the magnetic lead screw (MLS) transmission. The MLS enables the conversion of rotational ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

What Is Empaveli, and Why Does It Matter? First approved in 2021 for a rare blood disorder, Empaveli (pegcetacoplan) is now approved as the first targeted medicine for adults and children aged 12 ...

ARO-C3 treatment led to deep and sustained reductions in alternative pathway complement activity and proteinuria. ARO-C3, an investigational RNA interference-based therapy targeting hepatic expression ...

(RTTNews) - Novartis AG (NVS) announced that the U.S. Food and Drug Administration has approved oral Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy to reduce ...

1 The Reproductive Laboratory of Shenyang Jinghua Hospital, Shenyang, Liaoning, China 2 Department of Biotechnology, Shenyang Medical College, Shenyang, Liaoning, China Background: Polycystic Ovary ...

Tianjin Key Laboratory of Organic Solar Cells and Photochemical Conversion, Tianjin Key Laboratory of Drug Targeting and Bioimaging, School of Chemistry & Chemical Engineering, Tianjin University of ...